Factors Determining Admission to the Intensive Care Unit After Urologic Cancer Surgery and Clinical Outcomes

Introduction:This study aimed to identify the factors associated with postoperative intensive care unit (ICU) admission and to evaluate short-term clinical outcomes in patients undergoing surgery for urological malignancies.Methods: This retrospective observational study included 75 patients admitted to the ICU following elective surgery for kidney, bladder, or prostate cancer between January 1, 2023, and January 1, 2024.Demographic characteristics, comorbid conditions, and surgery-and anesthesia-related variables were recorded.Reasons for ICU admission, ICU length of stay, and 28-day mortality were analyzed; previously missing 28-day mortality data are now included and reported as 0%.Multivariable regression analysis was omitted because the sample size was small and its application in the previous manuscript was inappropriate. Results:The mean age of the patients was 66.710.9years, and 84% were male.Kidney cancer (45.3%) was the most common diagnosis, followed by bladder cancer (38.7%) and prostate cancer (16.0%).ICU admission was most frequently performed for postoperative monitoring (53.3%), followed by hemodynamic instability (32.0%) and respiratory failure (14.7%).The median ICU length of stay was 0 days (IQR: 0-1), with 65.3% of patients discharged on the same day.Conclusion: Most ICU admissions after urological cancer surgery were undertaken for short-term postoperative observation.Associations previously inferred from regression analysis between diabetes mellitus and sex were removed; only univariate differences are reported.These findings highlight the importance of perioperative risk assessment and may contribute to more efficient utilization of intensive care resources.